461 related articles for article (PubMed ID: 25016223)
1. Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation.
Bengsch B; Martin B; Thimme R
J Hepatol; 2014 Dec; 61(6):1212-9. PubMed ID: 25016223
[TBL] [Abstract][Full Text] [Related]
2. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
[TBL] [Abstract][Full Text] [Related]
3. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
Evans A; Riva A; Cooksley H; Phillips S; Puranik S; Nathwani A; Brett S; Chokshi S; Naoumov NV
Hepatology; 2008 Sep; 48(3):759-69. PubMed ID: 18697210
[TBL] [Abstract][Full Text] [Related]
4. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
[TBL] [Abstract][Full Text] [Related]
5. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
6. Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients.
Zhang Z; Jin B; Zhang JY; Xu B; Wang H; Shi M; Wherry EJ; Lau GK; Wang FS
J Hepatol; 2009 Jun; 50(6):1163-73. PubMed ID: 19395117
[TBL] [Abstract][Full Text] [Related]
7. [PD-1 up-regulation influenced apoptosis of HBV-specific CD8 T cells in patients with acute resolved hepatitis B].
Xu B; Zhang Z; Shi Y; Chen XY; Wang FS
Zhonghua Yi Xue Za Zhi; 2009 May; 89(17):1158-61. PubMed ID: 19595077
[TBL] [Abstract][Full Text] [Related]
8. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
[TBL] [Abstract][Full Text] [Related]
9. A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C.
Owusu Sekyere S; Suneetha PV; Kraft AR; Zhang S; Dietz J; Sarrazin C; Manns MP; Schlaphoff V; Cornberg M; Wedemeyer H
J Hepatol; 2015 Jan; 62(1):31-40. PubMed ID: 25131771
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir.
Sherman AC; Trehanpati N; Daucher M; Davey RT; Masur H; Sarin SK; Kottilil S; Kohli A
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):665-72. PubMed ID: 23259453
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro.
Rossi M; Vecchi A; Tiezzi C; Barili V; Fisicaro P; Penna A; Montali I; Daffis S; Fletcher SP; Gaggar A; Medley J; Graupe M; Lad L; Loglio A; Soffredini R; Borghi M; Pollicino T; Musolino C; Alfieri A; Brillo F; Laccabue D; Massari M; Boarini C; Abbati G; Pedrazzi G; Missale G; Lampertico P; Ferrari C; Boni C
Gut; 2023 Nov; 72(11):2123-2137. PubMed ID: 36717219
[TBL] [Abstract][Full Text] [Related]
12. Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection.
Ferrando-Martinez S; Snell Bennett A; Lino E; Gehring AJ; Feld J; Janssen HLA; Robbins SH
Front Immunol; 2021; 12():648420. PubMed ID: 34589081
[TBL] [Abstract][Full Text] [Related]
13. [HBV-specific CD8+ T cells for sustained HBeAg seroconversion after lamivudine therapy].
Lee CK; Han KH; Suh JH; Cho YS; Won SY; Chon CY; Moon YM; Park IS
Korean J Hepatol; 2005 Mar; 11(1):34-42. PubMed ID: 15788883
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
[TBL] [Abstract][Full Text] [Related]
15. Programmed death-1 expression is associated with the disease status in hepatitis B virus infection.
Ye P; Weng ZH; Zhang SL; Zhang JA; Zhao L; Dong JH; Jie SH; Pang R; Wei RH
World J Gastroenterol; 2008 Jul; 14(28):4551-7. PubMed ID: 18680238
[TBL] [Abstract][Full Text] [Related]
16. PD-1
Liu X; Li M; Wang X; Dang Z; Jiang Y; Wang X; Kong Y; Yang Z
Cancer Immunol Immunother; 2019 Dec; 68(12):2041-2054. PubMed ID: 31720814
[TBL] [Abstract][Full Text] [Related]
17. TIM-3 as a marker of exhaustion in CD8
Mohammadizad H; Shahbazi M; Hasanjani Roushan MR; Soltanzadeh-Yamchi M; Mohammadnia-Afrouzi M
Microb Pathog; 2019 Mar; 128():323-328. PubMed ID: 30660734
[TBL] [Abstract][Full Text] [Related]
18. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
[TBL] [Abstract][Full Text] [Related]
19. Hepatic expansion of virus-specific CD8
Wang H; Wu B; Li L; Hu L; Lin J; Jiang C; Cai G; Shen Q
Cell Immunol; 2017 Jan; 311():36-45. PubMed ID: 27743606
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
